Cargando…
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
[Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological co...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011926/ https://www.ncbi.nlm.nih.gov/pubmed/32901477 http://dx.doi.org/10.1021/acs.jmedchem.9b02057 |
_version_ | 1783673289408774144 |
---|---|
author | Pacifico, Salvatore Ferrari, Federica Albanese, Valentina Marzola, Erika Neto, Joaquim Azevedo Ruzza, Chiara Calò, Girolamo Preti, Delia Guerrini, Remo |
author_facet | Pacifico, Salvatore Ferrari, Federica Albanese, Valentina Marzola, Erika Neto, Joaquim Azevedo Ruzza, Chiara Calò, Girolamo Preti, Delia Guerrini, Remo |
author_sort | Pacifico, Salvatore |
collection | PubMed |
description | [Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH(2) is a useful strategy for obtaining G protein biased agonists for the NOP receptor. |
format | Online Article Text |
id | pubmed-8011926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80119262021-04-02 Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2) Pacifico, Salvatore Ferrari, Federica Albanese, Valentina Marzola, Erika Neto, Joaquim Azevedo Ruzza, Chiara Calò, Girolamo Preti, Delia Guerrini, Remo J Med Chem [Image: see text] Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH(2) is a useful strategy for obtaining G protein biased agonists for the NOP receptor. American Chemical Society 2020-09-09 2020-10-08 /pmc/articles/PMC8011926/ /pubmed/32901477 http://dx.doi.org/10.1021/acs.jmedchem.9b02057 Text en Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Pacifico, Salvatore Ferrari, Federica Albanese, Valentina Marzola, Erika Neto, Joaquim Azevedo Ruzza, Chiara Calò, Girolamo Preti, Delia Guerrini, Remo Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title | Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title_full | Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title_fullStr | Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title_full_unstemmed | Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title_short | Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2) |
title_sort | biased agonism at nociceptin/orphanin fq receptors:
a structure activity study on n/ofq(1–13)-nh(2) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011926/ https://www.ncbi.nlm.nih.gov/pubmed/32901477 http://dx.doi.org/10.1021/acs.jmedchem.9b02057 |
work_keys_str_mv | AT pacificosalvatore biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT ferrarifederica biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT albanesevalentina biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT marzolaerika biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT netojoaquimazevedo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT ruzzachiara biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT calogirolamo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT pretidelia biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 AT guerriniremo biasedagonismatnociceptinorphaninfqreceptorsastructureactivitystudyonnofq113nh2 |